These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 9157298

  • 41. Complications of therapeutic plasma exchange: a prospective study of 1,727 procedures.
    Shemin D, Briggs D, Greenan M.
    J Clin Apher; 2007; 22(5):270-6. PubMed ID: 17722046
    [Abstract] [Full Text] [Related]

  • 42. Rapid improvement of myasthenia gravis after plasma exchange.
    Nielsen VK, Paulson OB, Rosenkvist J, Holsøe E, Lefvert AK.
    Ann Neurol; 1982 Feb; 11(2):160-9. PubMed ID: 6280584
    [Abstract] [Full Text] [Related]

  • 43. Treatment of ocular symptoms in myasthenia gravis.
    Bhanushali MJ, Wuu J, Benatar M.
    Neurology; 2008 Oct 21; 71(17):1335-41. PubMed ID: 18936425
    [Abstract] [Full Text] [Related]

  • 44. Treatment and outcome of myasthenia gravis: retrospective multi-center analysis of 470 Japanese patients, 1999-2000.
    Kawaguchi N, Kuwabara S, Nemoto Y, Fukutake T, Satomura Y, Arimura K, Osame M, Hattori T, Study Group for Myasthenia Gravis in Japan.
    J Neurol Sci; 2004 Sep 15; 224(1-2):43-7. PubMed ID: 15450770
    [Abstract] [Full Text] [Related]

  • 45. [Successful perioperative management with plasma exchange for elderly patient with myasthenia gravis; report of a case].
    Takeshige M, Aoki T, Motono N, Shimada K, Nakayama T, Yazawa M.
    Kyobu Geka; 2009 Nov 15; 62(12):1105-7. PubMed ID: 19894581
    [Abstract] [Full Text] [Related]

  • 46. Experience with starting tacrolimus postoperatively after transsternal extended thymectomy in patients with myasthenia gravis.
    Ponseti JM, Azem J, Fort JM, López-Cano M, Vilallonga R, Gamez J, Armengol M.
    Curr Med Res Opin; 2006 May 15; 22(5):885-95. PubMed ID: 16709310
    [Abstract] [Full Text] [Related]

  • 47. [A case of myasthenia gravis with anti-MuSK antibodies showing a dramatic improvement with plasma exchange].
    Suzuki H, Motomura M, Yoshimura T, Shiraishi H, Mitsui Y, Hasegawa T, Atsumi M, Kitaguchi M, Kusunoki S.
    Rinsho Shinkeigaku; 2005 Jul 15; 45(7):510-3. PubMed ID: 16119834
    [Abstract] [Full Text] [Related]

  • 48. Clinical remission following plasmapheresis and corticosteroid treatment in a dog with acquired myasthenia gravis.
    Bartges JW, Klausner JS, Bostwick EF, Hakala JE, Lennon VA.
    J Am Vet Med Assoc; 1990 Apr 15; 196(8):1276-8. PubMed ID: 2332375
    [Abstract] [Full Text] [Related]

  • 49. Plasmapheresis in severe forms of myasthenia gravis.
    Morosetti M, Meloni C, Iani C, Caramia M, Galderisi C, Palombo G, Gallucci MT, Bernardi G, Casciani CU.
    Artif Organs; 1998 Feb 15; 22(2):129-34. PubMed ID: 9491902
    [Abstract] [Full Text] [Related]

  • 50. Tacrolimus for myasthenia gravis: a clinical study of 212 patients.
    Ponseti JM, Gamez J, Azem J, López-Cano M, Vilallonga R, Armengol M.
    Ann N Y Acad Sci; 2008 Feb 15; 1132():254-63. PubMed ID: 18096852
    [Abstract] [Full Text] [Related]

  • 51. [Treatment of myasthenia].
    Fève JR.
    Rev Prat; 1988 Oct 06; 38(22):1541-5. PubMed ID: 3206137
    [No Abstract] [Full Text] [Related]

  • 52. Plasmapheresis before thymectomy in myasthenia gravis: routine versus selective protocols.
    El-Bawab H, Hajjar W, Rafay M, Bamousa A, Khalil A, Al-Kattan K.
    Eur J Cardiothorac Surg; 2009 Mar 06; 35(3):392-7. PubMed ID: 19136275
    [Abstract] [Full Text] [Related]

  • 53. Safety of plasma exchange therapy in patients with myasthenia gravis.
    Ebadi H, Barth D, Bril V.
    Muscle Nerve; 2013 Apr 06; 47(4):510-4. PubMed ID: 23322564
    [Abstract] [Full Text] [Related]

  • 54. [Efficacy of plasma exchange combined with fetal hepacyties on viral hepatitis gravis].
    Zheng XH, Tang XP, Chen J.
    Hunan Yi Ke Da Xue Xue Bao; 2001 Oct 28; 26(5):437-9. PubMed ID: 12536493
    [Abstract] [Full Text] [Related]

  • 55. [Plasmapheresis-pulse therapy in myasthenia gravis].
    Jyoichi T, Noda Y, Mizuguchi M, Shimojo S, Miyahara T.
    Rinsho Shinkeigaku; 1988 Jan 28; 28(1):43-50. PubMed ID: 3383512
    [No Abstract] [Full Text] [Related]

  • 56. [Ocular myasthenia: clinical course and strategies for treatment].
    Marzo ME, Pérez López-Fraile I, Capablo JL, Ara JR, Usón M.
    Rev Neurol; 1998 Mar 28; 26(151):398-400. PubMed ID: 9585951
    [Abstract] [Full Text] [Related]

  • 57. Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: a randomized double-blind clinical trial.
    Gajdos P, Tranchant C, Clair B, Bolgert F, Eymard B, Stojkovic T, Attarian S, Chevret S, Myasthenia Gravis Clinical Study Group.
    Arch Neurol; 2005 Nov 28; 62(11):1689-93. PubMed ID: 16286541
    [Abstract] [Full Text] [Related]

  • 58. [Cholinergic crisis in a patient with myasthenia treated by plasma exchange and anticholinesterase agents].
    Pourrat O, Robert R, Neau JP, Deleplanque P, Alcalay D.
    Ann Med Interne (Paris); 1988 Nov 28; 139 Suppl 1():51-2. PubMed ID: 3247993
    [Abstract] [Full Text] [Related]

  • 59. Azathioprine in the treatment of myasthenia gravis.
    Witte AS, Cornblath DR, Parry GJ, Lisak RP, Schatz NJ.
    Ann Neurol; 1984 Jun 28; 15(6):602-5. PubMed ID: 6742794
    [Abstract] [Full Text] [Related]

  • 60. [Treatment of myasthenia gravis--pathophysiological evaluation of various forms of treatment and practical aspects of therapy (author's transl)].
    Ito N.
    No To Shinkei; 1980 Sep 28; 32(9):921-9. PubMed ID: 7437165
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.